Titre : Toxoplasmose

Toxoplasmose : Questions médicales fréquentes

Termes MeSH sélectionnés :

Bone Development
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Toxoplasmose : Questions médicales les plus fréquentes", "headline": "Toxoplasmose : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Toxoplasmose : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-02-26", "dateModified": "2025-02-20", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Toxoplasmose" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Coccidiose", "url": "https://questionsmedicales.fr/mesh/D003048", "about": { "@type": "MedicalCondition", "name": "Coccidiose", "code": { "@type": "MedicalCode", "code": "D003048", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C01.610.752.250" } } }, "about": { "@type": "MedicalCondition", "name": "Toxoplasmose", "alternateName": "Toxoplasmosis", "code": { "@type": "MedicalCode", "code": "D014123", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "J P Dubey", "url": "https://questionsmedicales.fr/author/J%20P%20Dubey", "affiliation": { "@type": "Organization", "name": "United States Department of Agriculture, Agricultural Research Service, Beltsville Agricultural Research Center, Building 1001, Beltsville, MD 20705-2350, USA." } }, { "@type": "Person", "name": "João M Furtado", "url": "https://questionsmedicales.fr/author/Jo%C3%A3o%20M%20Furtado", "affiliation": { "@type": "Organization", "name": "Department of Ophthalmology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil; Formerly of Casey Eye Institute, Oregon Health & Science University, USA." } }, { "@type": "Person", "name": "Uwe Pleyer", "url": "https://questionsmedicales.fr/author/Uwe%20Pleyer", "affiliation": { "@type": "Organization", "name": "Department of Ophthalmology, Charité Campus Virchow, University Faculty of Medicine, Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health; Institute of Medical Microbiology and German Reference Laboratory for Toxoplasma Infection, Faculty of Medicine University of Göttingen; Institute of Medical Microbiology and Hospital Epidemiology, Hannover Medical School (MHH); Unit 35: Gastrointestinal Infections, Zoonoses and Tropical Infections, Robert Koch Institute, Berlin; Unit 16: Mycotic and parasitic agents and mycobacteria, Robert Koch Institute, Berlin." } }, { "@type": "Person", "name": "Rubens Belfort", "url": "https://questionsmedicales.fr/author/Rubens%20Belfort", "affiliation": { "@type": "Organization", "name": "Department of Ophthalmology, Federal University of São Paulo, Paulista Medical School, São Paulo, SP, Brazil; Vision Institute, São Paulo, SP, Brazil." } }, { "@type": "Person", "name": "Padmamalini Mahendradas", "url": "https://questionsmedicales.fr/author/Padmamalini%20Mahendradas", "affiliation": { "@type": "Organization", "name": "Department of Uveitis and Ocular Immunology, Narayana Nethralaya, Bangalore, India." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "A real-time automated bone age assessment system based on the RUS-CHN method.", "datePublished": "2023-03-15", "url": "https://questionsmedicales.fr/article/37008947", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fendo.2023.1073219" } }, { "@type": "ScholarlyArticle", "name": "Cohort profile of an early life observational cohort in China: Bone and MicroBiOme onset (BAMBOO) study.", "datePublished": "2024-05-17", "url": "https://questionsmedicales.fr/article/38760054", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1136/bmjopen-2023-075417" } }, { "@type": "ScholarlyArticle", "name": "Correlation of skeletal development and midpalatal suture maturation.", "datePublished": "2024-09-16", "url": "https://questionsmedicales.fr/article/39285501", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s40001-024-02058-1" } }, { "@type": "ScholarlyArticle", "name": "No pubertal growth spurt, rapid bone maturation, and menarche post GnRHa treatment in girls with precocious puberty.", "datePublished": "2022-09-19", "url": "https://questionsmedicales.fr/article/36114751", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1515/jpem-2022-0389" } }, { "@type": "ScholarlyArticle", "name": "The Effects of a Physical Education Intervention Program on the Bone Properties of Second- and Third-Grade Pupils: A Cluster Randomized Controlled Trial.", "datePublished": "2022-05-26", "url": "https://questionsmedicales.fr/article/35618299", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1123/jpah.2021-0782" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Infection", "item": "https://questionsmedicales.fr/mesh/D007239" }, { "@type": "ListItem", "position": 3, "name": "Maladies parasitaires", "item": "https://questionsmedicales.fr/mesh/D010272" }, { "@type": "ListItem", "position": 4, "name": "Protozooses", "item": "https://questionsmedicales.fr/mesh/D011528" }, { "@type": "ListItem", "position": 5, "name": "Coccidiose", "item": "https://questionsmedicales.fr/mesh/D003048" }, { "@type": "ListItem", "position": 6, "name": "Toxoplasmose", "item": "https://questionsmedicales.fr/mesh/D014123" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Toxoplasmose - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Toxoplasmose", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-16", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Toxoplasmose", "description": "Comment diagnostique-t-on la toxoplasmose ?\nQuels tests sont utilisés pour la toxoplasmose ?\nLa biopsie est-elle nécessaire pour diagnostiquer la toxoplasmose ?\nPeut-on diagnostiquer la toxoplasmose par imagerie ?\nQuels symptômes indiquent un test de toxoplasmose ?", "url": "https://questionsmedicales.fr/mesh/D014123?mesh_terms=Bone+Development&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Toxoplasmose", "description": "Quels sont les symptômes courants de la toxoplasmose ?\nLa toxoplasmose peut-elle être asymptomatique ?\nQuels symptômes chez les immunodéprimés ?\nY a-t-il des symptômes spécifiques chez les femmes enceintes ?\nComment se manifeste la toxoplasmose oculaire ?", "url": "https://questionsmedicales.fr/mesh/D014123?mesh_terms=Bone+Development&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Toxoplasmose", "description": "Comment prévenir la toxoplasmose ?\nLes femmes enceintes doivent-elles prendre des précautions ?\nLe lavage des mains aide-t-il à prévenir la toxoplasmose ?\nLes chats peuvent-ils transmettre la toxoplasmose ?\nLes jardins potagers présentent-ils un risque ?", "url": "https://questionsmedicales.fr/mesh/D014123?mesh_terms=Bone+Development&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Toxoplasmose", "description": "Quel est le traitement standard de la toxoplasmose ?\nLes antibiotiques sont-ils efficaces contre la toxoplasmose ?\nLe traitement est-il nécessaire pour tous les cas ?\nCombien de temps dure le traitement de la toxoplasmose ?\nY a-t-il des effets secondaires au traitement ?", "url": "https://questionsmedicales.fr/mesh/D014123?mesh_terms=Bone+Development&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Toxoplasmose", "description": "Quelles sont les complications possibles de la toxoplasmose ?\nLa toxoplasmose peut-elle affecter le fœtus ?\nQuels risques pour les personnes immunodéprimées ?\nLa toxoplasmose peut-elle causer des problèmes neurologiques ?\nY a-t-il un risque de réinfection ?", "url": "https://questionsmedicales.fr/mesh/D014123?mesh_terms=Bone+Development&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Toxoplasmose", "description": "Qui est le plus à risque de toxoplasmose ?\nLes personnes âgées sont-elles plus à risque ?\nLes jardiniers sont-ils à risque ?\nLes voyageurs dans certains pays sont-ils à risque ?\nLes personnes qui consomment de la viande crue sont-elles à risque ?", "url": "https://questionsmedicales.fr/mesh/D014123?mesh_terms=Bone+Development&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostique-t-on la toxoplasmose ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur des tests sérologiques détectant les anticorps anti-Toxoplasma." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour la toxoplasmose ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests IgG et IgM sont couramment utilisés pour évaluer l'infection." } }, { "@type": "Question", "name": "La biopsie est-elle nécessaire pour diagnostiquer la toxoplasmose ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "La biopsie est rarement nécessaire, sauf en cas de complications neurologiques." } }, { "@type": "Question", "name": "Peut-on diagnostiquer la toxoplasmose par imagerie ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'imagerie cérébrale peut montrer des lésions typiques chez les patients immunodéprimés." } }, { "@type": "Question", "name": "Quels symptômes indiquent un test de toxoplasmose ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme la fièvre, la fatigue ou des douleurs musculaires peuvent justifier un test." } }, { "@type": "Question", "name": "Quels sont les symptômes courants de la toxoplasmose ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent fièvre, fatigue, douleurs musculaires et ganglions enflés." } }, { "@type": "Question", "name": "La toxoplasmose peut-elle être asymptomatique ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, de nombreuses personnes infectées ne présentent aucun symptôme visible." } }, { "@type": "Question", "name": "Quels symptômes chez les immunodéprimés ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Chez les immunodéprimés, la toxoplasmose peut provoquer des symptômes neurologiques graves." } }, { "@type": "Question", "name": "Y a-t-il des symptômes spécifiques chez les femmes enceintes ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Les femmes enceintes peuvent transmettre l'infection au fœtus, entraînant des malformations." } }, { "@type": "Question", "name": "Comment se manifeste la toxoplasmose oculaire ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "La toxoplasmose oculaire peut provoquer des douleurs, une vision floue et des lésions rétiniennes." } }, { "@type": "Question", "name": "Comment prévenir la toxoplasmose ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Évitez de consommer de la viande crue, lavez les fruits et légumes, et évitez les excréments de chat." } }, { "@type": "Question", "name": "Les femmes enceintes doivent-elles prendre des précautions ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles doivent éviter les contacts avec les chats et consommer des aliments bien cuits." } }, { "@type": "Question", "name": "Le lavage des mains aide-t-il à prévenir la toxoplasmose ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un bon lavage des mains après avoir manipulé de la viande ou des excréments de chat est crucial." } }, { "@type": "Question", "name": "Les chats peuvent-ils transmettre la toxoplasmose ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les chats sont des hôtes définitifs et peuvent excréter des oocystes dans leurs selles." } }, { "@type": "Question", "name": "Les jardins potagers présentent-ils un risque ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les jardins peuvent être contaminés par des oocystes, surtout si des chats y ont accès." } }, { "@type": "Question", "name": "Quel est le traitement standard de la toxoplasmose ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement standard inclut la pyriméthamine et la sulfadiazine, souvent avec de l'acide folique." } }, { "@type": "Question", "name": "Les antibiotiques sont-ils efficaces contre la toxoplasmose ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Non, les antibiotiques ne sont pas efficaces; des antiparasitaires spécifiques sont nécessaires." } }, { "@type": "Question", "name": "Le traitement est-il nécessaire pour tous les cas ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement n'est pas toujours nécessaire pour les cas asymptomatiques ou bénins." } }, { "@type": "Question", "name": "Combien de temps dure le traitement de la toxoplasmose ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement dure généralement de 4 à 6 semaines, selon la gravité de l'infection." } }, { "@type": "Question", "name": "Y a-t-il des effets secondaires au traitement ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des effets secondaires comme des nausées, des éruptions cutanées ou des troubles sanguins peuvent survenir." } }, { "@type": "Question", "name": "Quelles sont les complications possibles de la toxoplasmose ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des lésions cérébrales, des problèmes oculaires et des infections systémiques." } }, { "@type": "Question", "name": "La toxoplasmose peut-elle affecter le fœtus ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'infection pendant la grossesse peut entraîner des malformations congénitales chez le fœtus." } }, { "@type": "Question", "name": "Quels risques pour les personnes immunodéprimées ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Les personnes immunodéprimées courent un risque accru de complications graves, notamment neurologiques." } }, { "@type": "Question", "name": "La toxoplasmose peut-elle causer des problèmes neurologiques ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut provoquer des encéphalites et d'autres troubles neurologiques chez les patients à risque." } }, { "@type": "Question", "name": "Y a-t-il un risque de réinfection ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, même après une infection, il est possible de contracter à nouveau la toxoplasmose." } }, { "@type": "Question", "name": "Qui est le plus à risque de toxoplasmose ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les personnes immunodéprimées, comme celles atteintes du VIH/SIDA, sont les plus à risque." } }, { "@type": "Question", "name": "Les personnes âgées sont-elles plus à risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes âgées peuvent avoir un système immunitaire affaibli, augmentant le risque." } }, { "@type": "Question", "name": "Les jardiniers sont-ils à risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les jardiniers peuvent être exposés aux oocystes en manipulant le sol contaminé." } }, { "@type": "Question", "name": "Les voyageurs dans certains pays sont-ils à risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les voyageurs dans des régions où la toxoplasmose est endémique courent un risque accru." } }, { "@type": "Question", "name": "Les personnes qui consomment de la viande crue sont-elles à risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la consommation de viande crue ou mal cuite est un facteur de risque majeur pour l'infection." } } ] } ] }

Sources (10000 au total)

A real-time automated bone age assessment system based on the RUS-CHN method.

Bone age is the age of skeletal development and is a direct indicator of physical growth and development in children. Most bone age assessment (BAA) systems use direct regression with the entire hand ... Key bone grades and locations were determined using three real-time target detection models and Key Bone Search (KBS) post-processing using the RUS-CHN approach, and then the age of the bones was pred... The three real-time models achieved good results with an average (IOU) of no less than 0.9 in all key bones. The most accurate outcomes for the inference results utilizing KBS were a MAE of 0.35 years... We developed an automated end-to-end BAA system that is based on real-time target detection, obtaining key bone developmental grade and location in a single pass with the aid of KBS, and using Lightgb...

Cohort profile of an early life observational cohort in China: Bone and MicroBiOme onset (BAMBOO) study.

The Bone And MicroBiOme Onset (BAMBOO) study is an ongoing prospective observational cohort study conducted in Tianjin, China, aiming to determine age-appropriate trajectories for microbiome maturatio... The recruitment started in September 2021 and was completed in February 2023. A total of 1380 subjects were recruited, 690 at birth (group 1) and 690 at 6 months of age (group 2). Groups 1 and 2 will ... The age of the mothers was 31.1±3.7 (mean±SD), and the birth weight of infants was 3.3±0.5 kg with an incidence of caesarean section 50.4%. Food diary information of the first 100 subjects showed that... Data collection will be completed in August 2025. Four stage-statistical analyses will be performed as the cohort reaches certain age thresholds before the final report. Analysis of BAMBOO data will b... ChiCTR2100049972....

Correlation of skeletal development and midpalatal suture maturation.

The aim of our study is to determine the relationship between MPS maturation and CVM stage determined from CBCTs.... CBCT images of 130 individuals (75 females, 55 males) with a mean age of 15.04 ± 3.11 (9.56-25.05 years) were analyzed. Images were analyzed using the i-CAT Vision software program. The cephalometric ... Significant correlations were found between CVM and MPS maturation stages. Positive LHR values of cervical vertebral stages were obtained to define the maturation stages of the midpalatal suture. LHR ... MPS fusion is more likely to occur after CS4. The correlation between the CVM and MPS maturation stages is significant (r = 0.858). CVM stages CS2, CS4, and CS6 can be a preliminary indicator for MPS ... A significant relationship exists between skeletal developmental stages and suture maturation....

No pubertal growth spurt, rapid bone maturation, and menarche post GnRHa treatment in girls with precocious puberty.

To study total growth, rate of bone maturation, and menarche after discontinuation of Gonadotropin releasing hormone agonist (GnRHa) treatment for central precocious puberty (CPP).... Twenty girls with CPP on treatment with GnRHa were followed from discontinuation of treatment to final height (FH). Height, height velocity (HV), and bone age were measured every 6 months. Age at mena... Once treatment is discontinued, rate of bone maturation (bone age [BA]/chronological [CA]) accelerated from 0.7 ± 0.3 at end of treatment to 1.2 ± 0.8 post treatment, similar to BA/CA prior to treatme... A pubertal growth spurt does not usually occur after treatment with GnRHa in girls with CPP. Rate of bone maturation accelerates post treatment. These factors are important in assessing optimal height...

The Effects of a Physical Education Intervention Program on the Bone Properties of Second- and Third-Grade Pupils: A Cluster Randomized Controlled Trial.

Many young children do not participate in sufficient physical activity for promoting optimal bone growth. The objective of this study was to investigate the effect of young children who participated i... A cluster randomized controlled trial was conducted, in which classes were randomly assigned to the intervention or control groups. A total of 295 (50.17% girls) children from the second and third gra... Distal radius properties improved significantly for both boys and girls in the intervention group (boys: meanpre = 3769.95, meanpost = 3875.08, Δ = 2.80%; girls: meanpre = 3766.27, meanpost = 3890.83,... These findings indicate that distal radius properties of children can be positively affected by a short, easy to implement intervention program that does not require special resources....

Skeletal age assessed by TW2 using 20-bone, carpal and RUS score systems: Intra-observer and inter-observer agreement among male pubertal soccer players.

The purpose of this study was to determine intra- and inter-observer agreement for the three skeletal ages derived from the TW2 method among male pubertal soccer players. The sample included 142 parti...

Plasma exosome miRNA-26b-3p derived from idiopathic short stature impairs longitudinal bone growth via the AKAP2/ERK1/2 axis.

Currently, the etiology of idiopathic short stature (ISS) is still unclear. The poor understanding of the molecular mechanisms of ISS has largely restricted this strategy towards safe and effective cl... The plasma exosomes of ISS children were co-cultured with normal human chondrocytes. The differential expression of exosome miRNA between ISS and normal children was identified via high-throughput mic... Chondrocytes proliferation and endochondral ossification were suppressed after coculture of ISS plasma exosomes with human normal chondrocytes. High-throughput microRNA sequencing and RT-qPCR confirme... This study is the first to confirm that miR-26b-3p overexpression in ISS plasma exosomes leads to disorders in proliferation and endochondral ossification of growth plate cartilage via inhibition of A...